Twisting the night away: A review of the neurobiology, genetics, diagnosis, and treatment of shift work disorder

CNS Spectrums

Volumn 18, Issue SUPPL.1, 2013, Pages 45-54

  Morrissette, Debbi Ann ^a,b,c  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b Palomar Community College   (United States)

^c NEUROSCIENCE EDUCATION INSTITUTE   (United States)

Author keywords

Armodafinil; circadian rhythm disorder; melatonin; modafinil; molecular clock

Indexed keywords

ARMODAFINIL; DOXEPIN; MELATONIN; METHAMPHETAMINE; MODAFINIL; TRANSCRIPTION FACTOR CLOCK; TRAZODONE;

ADAPTATION; ANXIETY DISORDER; CARDIOMETABOLIC RISK; CIRCADIAN RHYTHM; CLOCK GENE; CONFUSION; DEPRESSION; DIGESTIVE SYSTEM CANCER; DIZZINESS; DOSE RESPONSE; DRUG HALF LIFE; DRUG SAFETY; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; GENETIC ANALYSIS; HEADACHE; HUMAN; INFLAMMATORY BOWEL DISEASE; INSOMNIA; IRRITABLE COLON; LOW DRUG DOSE; MOLECULAR CLOCK; MOOD DISORDER; NAUSEA; NEUROBIOLOGY; OCCUPATIONAL DISEASE; PHOTOTHERAPY; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; SHIFT WORK DISORDER; SHIFT WORKER; SLEEP THERAPY; WAKEFULNESS;

ANTIDEPRESSIVE AGENTS; BIOLOGICAL CLOCKS; CENTRAL NERVOUS SYSTEM STIMULANTS; CIRCADIAN RHYTHM; HUMANS; HYGIENE; HYPNOTICS AND SEDATIVES; MELATONIN; PHOTOTHERAPY; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 84890589602     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285291300076X     Document Type: Review

References (56)

1. Wright KP Jr, Bogan RK, Wyatt JK. Shift work and the assessment and management of shift work disorder (SWD). Sleep Med Rev. 2013; 17(1): 41-54.
2. Barger LK, Ogeil RP, Drake CL, et al. Validation of a questionnaire to screen for shift work disorder. Sleep. 2012; 35(12): 1693-1703.
3. Di Milia L, Waage S, Pallesen S, Bjorvatn B. Shift work disorder in a random population sample-prevalence and comorbidities. PLoS One. 2013; 8(1): e55306.
4. Saksvik IB, Bjorvatn B, Hetland H, Sandal GM, Pallesen S. Individual differences in tolerance to shift work-a systematic review. Sleep Med Rev. 2011; 15(4): 221-235.
5. Culpepper L. The social and economic burden of shift-work disorder. J Fam Pract. 2010; 59(1 Suppl): S3-S11.
6. Schwartz JR. Recognition of shift-work disorder in primary care. J Fam Pract. 2010; 59(1 Suppl): S18-S23.
7. Recognition and assessment of shift work disorder. J Clin Psychiatry. 2011;72(2):248-257.
8. Buhr ED, Takahashi JS. Molecular components of the mammalian circadian clock. Handb Exp Pharmacol. 2013;(217): 3-27.
9. Shigeyoshi Y, Taguchi K, Yamamoto S, et al. Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell. 1997; 91(7): 1043-1053.
10. Stahl SM. Stahl's Essential Psychopharmacology, 4th ed. New York: Cambridge University Press; 2013.
11. Vogel M, Braungardt T, Meyer W, Schneider W. The effects of shift work on physical and mental health. J Neural Transm. 2012; 119(10): 1121-1132.
12. Lamont EW, James FO, Boivin DB, Cermakian N. From circadian clock gene expression to pathologies. Sleep Med. 2007; 8(6): 547-556.
13. Leloup JC, Goldbeter A. Modelling the dual role of Per phosphorylation and its effect on the period and phase of the mammalian circadian clock. IET Syst Biol. 2011; 5(1): 44.
14. Rouch I, Wild P, Ansiau D, Marquie JC. Shiftwork experience, age and cognitive performance. Ergonomics. 2005; 48(10): 1282-1293.
15. Wagstaff AS, Sigstad Lie JA. Shift and night work and long working hours-a systematic review of safety implications. Scand J Work Environ Health. 2011; 37(3): 173-185.
16. Froy O. Metabolism and circadian rhythms-implications for obesity. Endocr Rev. 2010; 31(1): 1-24.
17. Boggild H, Knutsson A. Shift work, risk factors and cardiovascular disease. Scand J Work Environ Health. 1999; 25(2): 85-99.
18. Green CB, Takahashi JS, Bass J. The meter of metabolism. Cell. 2008; 134(5): 728-742.
19. Wang XS, Armstrong ME, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond). 2011; 61(2): 78-89.
20. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007; 8(12): 1065-1066.
21. Ravindra T, Lakshmi NK, Ahuja YR. Melatonin in pathogenesis and therapy of cancer. Indian J Med Sci. 2006; 60(12): 523-535.
22. Rodriguez C, Martin V, Herrera F, et al. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. Int J Mol Sci. 2013; 14(4): 6597-6613.
23. Takahashi JS, Hong HK, Ko CH, McDearmon EL. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet. 2008; 9(10): 764-775.
24. Nojkov B, Rubenstein JH, Chey WD, Hoogerwerf WA. The impact of rotating shift work on the prevalence of irritable bowel syndrome in nurses. Am J Gastroenterol. 2010; 105(4): 842-847.
25. Konturek PC, Brzozowski T, Konturek SJ. Gut clock: implication of circadian rhythms in the gastrointestinal tract. J Physiol Pharmacol. 2011; 62(2): 139-150.
26. Knutsson A, Boggild H. Gastrointestinal disorders among shift workers. Scand J Work Environ Health. 2010; 36(2): 85-95.
27. Hoogerwerf WA. Role of clock genes in gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol. 2010; 299(3): G549-G555.
28. Lu WZ, Gwee KA, Moochhalla S, Ho KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2005; 22(10): 927-934.
29. Meyer JH, Ginovart N, Boovariwala A, et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006; 63(11): 1209-1216.
30. Drake CL, Roehrs T, Richardson G, Walsh JK, Roth T. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep. 2004; 27(8): 1453-1462.
31. Boivin DB, Boudreau P, James FO, Kin NM. Photic resetting in night-shift work: impact on nurses' sleep. Chronobiol Int. 2012; 29(5): 619-628.
32. Boivin DB, Boudreau P, Tremblay GM. Phototherapy and orangetinted goggles for night-shift adaptation of police officers on patrol. Chronobiol Int. 2012; 29(5): 629-640.
33. Dallaspezia S, Benedetti F. Chronobiological therapy for mood disorders. Expert Rev Neurother. 2011; 11(7): 961-970.
34. Terman M, Terman JS. Circadian rhythm phase advance with dawn simulation treatment for winter depression. J Biol Rhythms. 2010; 25(4): 297-301.
35. Roth T. Appropriate therapeutic selection for patients with shift work disorder. Sleep Med. 2012; 13(4): 335-341.
36. Folkard S, Arendt J, Clark M. Can melatonin improve shift workers' tolerance of the night shift? Some preliminary findings. Chronobiol Int. 1993; 10(5): 315-320.
37. Yoon IY, Song BG. Role of morning melatonin administration and attenuation of sunlight exposure in improving adaptation of nightshift workers. Chronobiol Int. 2002; 19(5): 903-913.
38. Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. Travel Med Infect Dis. 2008; 6(1-2): 17-28.
39. Markwald RR, Lee-Chiong TL, Burke TM, Snider JA, Wright KP Jr. Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep. Sleep. 2010; 33(6): 825-831.
40. Wisor JP, Eriksson KS. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience. 2005; 132(4): 1027-1034.
41. Ishizuka T, Murotani T, Yamatodani A. Action of modafinil through histaminergic and orexinergic neurons. Vitam Horm. 2012; 89: 259-278.
42. Gallopin T, Luppi PH, Rambert FA, Frydman A, Fort P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep. 2004; 27(1): 19-25.
43. Madras BK, Xie Z, Lin Z, et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther. 2006; 319(2): 561-569.
44. Gerrard P, Malcolm R. Mechanisms of modafinil: a review of current research. Neuropsychiatr Dis Treat. 2007; 3(3): 349-364.
45. Bogan RK. Armodafinil in the treatment of excessive sleepiness. Expert Opin Pharmacother. 2010; 11(6): 993-1002.
46. Darwish M, Bond M, Ezzet F. Armodafinil and modafinil in patients with excessive sleepiness associated with shift work disorder: a pharmacokinetic/ pharmacodynamic model for predicting and comparing their concentration-effect relationships. J Clin Pharmacol. 2012; 52(9): 1328-1342.
47. Darwish M, Kirby M, D'Andrea DM, et al. Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study. Clin Ther. 2010; 32(12): 2074-2087.
48. Erman MK, Seiden DJ, Yang R, Dammerman R. Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder. J Occup Environ Med. 2011; 53(12): 1460-1465.
49. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol. 2000; 14(1): 53-60.
50. Stahl SM. ed. Stahl's Essential Psychopharmacology: The Prescriber's Guide, 4th ed. New York: Cambridge University Press; 2011.
51. Davies M, Wilton L, Shakir S. Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescriptionevent monitoring study. Drug Saf. 2013; 36(4): 237-246.
52. Hart CL, Ward AS, Haney M, Nasser J, Foltin RW. Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work. Psychopharmacology (Berl). 2003; 169(1): 42-51.
53. Schweitzer PK, Randazzo AC, Stone K, Erman M, Walsh JK. Laboratory and field studies of naps and caffeine as practical countermeasures for sleep-wake problems associated with night work. Sleep. 2006; 29(1): 39-50.
54. Ker K, Edwards PJ, Felix LM, Blackhall K, Roberts I. Caffeine for the prevention of injuries and errors in shift workers. Cochrane Database Syst Rev. 2010;(5): CD008508.
55. Cauli O, Morelli M. Caffeine and the dopaminergic system. Behav Pharmacol. 2005; 16(2): 63-77.
56. Einother SJ, Giesbrecht T. Caffeine as an attention enhancer: reviewing existing assumptions. Psychopharmacology (Berl). 2013; 225(2): 251-274.